Trials / Conditions / Cough Variant Asthma

Cough Variant Asthma

13 registered clinical trials studyying Cough Variant Asthma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA NCT06590740	AstraZeneca	Phase 4
Recruiting	Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol NCT03105843	Dr. Diane Lougheed	Phase 4
Unknown	Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese NCT05459805	The First Affiliated Hospital of Zhejiang Chinese Medical University	N/A
Completed	MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough NCT03363698	Medical University of Warsaw	—
Unknown	The Efficacy of Budesonide/Formoterol in Cough Variant Asthma NCT04171180	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Completed	Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma NCT04203472	Medical University of Warsaw	N/A
Completed	Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma NCT03573284	Zhujiang Hospital	N/A
Unknown	Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. NCT03319043	Shanghai University of Traditional Chinese Medicine	Phase 1 / Phase 2
Unknown	Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data NCT03169699	KK Women's and Children's Hospital	—
Unknown	The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma NCT02002754	The First Affiliated Hospital of Guangzhou Medical University	Phase 4
Unknown	Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) NCT01170429	Shanghai Jiao Tong University School of Medicine	Phase 4
Completed	Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challen NCT01064245	Dr. Diane Lougheed	N/A
Completed	Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients NCT00660114	AstraZeneca	—